Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab

Leukemia and Lymphoma

Volumn 52, Issue 5, 2011, Pages 910-912

  Leclerc, Mathieu ^a   Lesesve, Jean François ^b   Gaillard, Baptiste ^a   Troussard, Xavier ^c   Tourbah, Ayman ^d   Debouverie, Marc ^b   Daliphard, Sylvie ^a   Delmer, Alain ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; IMMUNOGLOBULIN M; NATALIZUMAB;

ARTICLE; BASOPHIL; BINUCLEATED LYMPHOCYTE; BLOOD CELL COUNT; BLOOD SMEAR; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; ISOCHROMOSOME; LEUKOCYTOSIS; LYMPHOCYTE; LYMPHOCYTE STRUCTURE; LYMPHOCYTE TRANSFORMATION; LYMPHOCYTOSIS; MULTINUCLEAR CELL; MULTIPLE SCLEROSIS; PERSISTENT POLYCLONAL B CELL LYMPHOCYTOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; LYMPHOCYTES; LYMPHOCYTOSIS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 79955067208     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.551156     Document Type: Article

References (9)

1. Bhat SA, Czuczman MS. Novel antibodies in the treatment of non-Hodgkin's lymphoma. Neth J Med 2009;67: 311-321.
2. Kim YH, Duvic M, Obitz E, et al. Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood 2007;109:4655-4662. (Pubitemid 46827755)
3. Faguer S, Launay F, Ysebaert L, et al. Acute cutaneous T-cell lymphoma transformation during treatment with alemtuzumab. Br J Dermatol 2007;157:841-842. (Pubitemid 47389908)
4. Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988;132:265-277.
5. Vergier B, de Muret A, Beylot-Barry M, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 2000;95:2212-2218. (Pubitemid 30167716)
6. Barberio E, Thomas L, Skowron F, Balme B, Dalle S. Transformed mycosis fungoides: clinicopathological features and outcome. Br J Dermatol 2007;157:284-289. (Pubitemid 47083853)
7. Prochazkova M, Chevret E, Beylot-Barry M, et al. Large cell transformation of mycosis fungoides: tetraploidization within skin tumor large cells. Cancer Genet Cytogenet 2005;163:1-6. (Pubitemid 41597002)
8. Ponti R, Fierro MT, Quaglino P, et al. TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol 2008;128:1030-1038. (Pubitemid 351374302)
9. Villadsen LS, Skov L, Dam TN, et al. In situ depletion of CD4+ T cells in human skin by zanolimumab. Arch Dermatol Res 2007;298:449-455. (Pubitemid 46144206)